Condition: Cholestasis of Pregnancy · Sponsor: University Hospital, Brest
This observational prospective study will help to determine if an immune process similar to allograft rejection is responsible for the occurrence of an intrahepatic cholestasis of pregnancy (ICP). If so, it would suggest the potential benefit of immunomodulatory therapeutics.
This description comes directly from the study's public registry record.
Claire de Moreuil · 02 98 14 53 03 · claire.demoreuil@chu-brest.fr
Philippe Merviel · 02-98-22-39-70 · philippe.merviel@chu-brest.fr
Always discuss trial participation with your own doctor first.
| CHU Angers | Angers, France | Not Yet Recruiting |
| Polyclinique KERAUDREN | Brest, France | Recruiting |
| CHU de Brest | Brest, France | Recruiting |
| CHU de Caen | Caen, France | Recruiting |
| CH de Chambery | Chambéry, France | Recruiting |
| CH Bretagne Sud | Lorient, France | Recruiting |
| CHU Nantes | Nantes, France | Recruiting |
| CH de Quimper | Quimper, France | Recruiting |
| CHU de Rennes | Rennes, France | Recruiting |
| CH St Brieuc | Saint-Brieuc, France | Recruiting |
| CHU de Tours | Tours, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05197387